Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.23 CNY
303.39 M CNY
4.54 B CNY
436.52 M
About LUSHANG FREDA PHARMACEUTICAL
Sector
Industry
CEO
Chun Ming Gao
Website
Headquarters
Jinan
Founded
1993
ISIN
CNE000001147
FIGI
BBG000DM5DM8
Lushang Freda Pharmaceutical Co., Ltd. engages in real estate activities. The company focuses on developing and managing real estate, property management, construction, installation, and architectural decoration. It also operates biomedicine and ecological health industry development. The company was founded on April 21, 1993 and is headquartered in Jinan, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600223 is 7.39 CNY — it has increased by 4.67% in the past 24 hours. Watch LUSHANG FREDA PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange LUSHANG FREDA PHARMACEUTICAL stocks are traded under the ticker 600223.
600223 stock has fallen by −0.81% compared to the previous week, the month change is a 6.18% rise, over the last year LUSHANG FREDA PHARMACEUTICAL has showed a −21.38% decrease.
We've gathered analysts' opinions on LUSHANG FREDA PHARMACEUTICAL future price: according to them, 600223 price has a max estimate of 9.00 CNY and a min estimate of 8.28 CNY. Watch 600223 chart and read a more detailed LUSHANG FREDA PHARMACEUTICAL stock forecast: see what analysts think of LUSHANG FREDA PHARMACEUTICAL and suggest that you do with its stocks.
600223 reached its all-time high on May 31, 2021 with the price of 19.10 CNY, and its all-time low was 1.94 CNY and was reached on May 8, 2006. View more price dynamics on 600223 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600223 stock is 6.86% volatile and has beta coefficient of 1.49. Track LUSHANG FREDA PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is LUSHANG FREDA PHARMACEUTICAL there?
Today LUSHANG FREDA PHARMACEUTICAL has the market capitalization of 7.51 B, it has decreased by −1.63% over the last week.
Yes, you can track LUSHANG FREDA PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
LUSHANG FREDA PHARMACEUTICAL is going to release the next earnings report on Mar 28, 2025. Keep track of upcoming events with our Earnings Calendar.
600223 earnings for the last quarter are 0.04 CNY per share, whereas the estimation was 0.07 CNY resulting in a −42.86% surprise. The estimated earnings for the next quarter are 0.11 CNY per share. See more details about LUSHANG FREDA PHARMACEUTICAL earnings.
600223 net income for the last quarter is 43.91 M CNY, while the quarter before that showed 68.21 M CNY of net income which accounts for −35.62% change. Track more LUSHANG FREDA PHARMACEUTICAL financial stats to get the full picture.
LUSHANG FREDA PHARMACEUTICAL dividend yield was 1.04% in 2023, and payout ratio reached 33.51%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 3.65 K employees. See our rating of the largest employees — is LUSHANG FREDA PHARMACEUTICAL on this list?
Like other stocks, 600223 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LUSHANG FREDA PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LUSHANG FREDA PHARMACEUTICAL technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LUSHANG FREDA PHARMACEUTICAL stock shows the sell signal. See more of LUSHANG FREDA PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.